| Company Name: |
BOC Sciences |
| Tel: |
1-631-485-4226; 16314854226 |
| Email: |
info@bocsci.com |
Lys-[Des-Arg9]Bradykinin TFA manufacturers
|
| | Lys-[Des-Arg9]Bradykinin TFA Basic information |
| | Lys-[Des-Arg9]Bradykinin TFA Chemical Properties |
| form | Solid | | color | White to off-white |
| | Lys-[Des-Arg9]Bradykinin TFA Usage And Synthesis |
| Uses | Lys-[Des-Arg9]Bradykinin TFA, a naturally occurring kinin, is a potent and highly selective bradykinin B1 receptor agonist with a Ki of 0.12 nM, 1.7 nM and 0.23 nM for human, mouse and rabbit B1 receptors, respectively. Lys-[Des-Arg9]Bradykinin TFA has low inhibitory activity on B2 receptors[1][2]. | | in vivo | Lys-[Des-Arg9]Bradykinin (1 μg; intra-artenal injection; New Zealand White rabbits) treatment reduces peripheral vascular resistance in LPS-induced rabbits, but the effect is brief (T1/2 is 118-195 s)[3]. | | IC 50 | Bradykinin B1 Receptor (B1R) | | References | [1] Rosalind Gulliver, et al. Lys-des[Arg9]-bradykinin alters migration and production of interleukin-12 in monocyte-derived dendritic cells. Am J Respir Cell Mol Biol. 2011 Sep;45(3):542-9. DOI:10.1165/rcmb.2010-0238OC
[2] L M Fredrik Leeb-Lundberg, et al. International union of pharmacology. XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences. Pharmacol Rev. 2005 Mar;57(1):27-77. DOI:10.1124/pr.57.1.2
[3] G Drapeau, et al. Hypotensive effects of Lys-des-Arg9-bradykinin and metabolically protected agonists of B1 receptors for kinins. J Pharmacol Exp Ther. 1991 Dec;259(3):997-1003. PMID:1662280 |
| | Lys-[Des-Arg9]Bradykinin TFA Preparation Products And Raw materials |
|